Over 900 professionals representing pharmas/biopharmas, biotechs, CROs and multiple regulatory agencies working on both small and large molecules bioanalysis participated in the 12th WRIB (Workshop on Recent Issues in Bioanalysis) on April 9-13, 2018 in Philadelphia, PA, USA.
The 2018 White Paper in Bioanalysis from the 12th was published on Journal Bioanaysis.
The 12th WRIB featured again the novel and unique 3-Day Sequential Program during the Main Workshop Days (Day 1, Day 2, and Day 3) with no parallel sessions for a Full immersion in Bioanalysis. Moreover, attendees have the flexibility to choose Main Workshop Days based on their specific track of interest and learning needs.
In addition to the 3-Day Sequential Main Workshop Days, there were 6 Full-Day Training Courses/Specialized Sessions covering topics on Small Molecules, Large Molecules, Biotherapeutics, Biomarkers, Immunogenicity, Oligonucleotides, LCMS, Hybrid LBA/LCMS, LBA/Cell-based Assays, and Flow cytometry spreading throughout the week to give attendees many choices to combine Main Workshop Days and Courses to maximize the learning process at any level in any field of expertise.
Participating Regulators at the 12th WRIB again included all Major and Influential Regulatory Agencies in North America, Europe, Latin America, and Asia.
Like the previous editions, 12th WRIB was again
High quality, better compliance to regulations, and scientific excellence have been and will always be the foundation of the WRIB!
What made WRIB Special?
In this busy and fast paced environment, it is great to attend a conference that organizes everything for you so all you need to do is to focus on your learning: